Ceo's Note
  About us
  Arbidol Hydrochloride granule
  Levofloxacin Lactate injection
  Lomefloxacin Hydrochloride...
  Itopride Hydrochloride
  Fleroxacin injection
  Clarithromycin capsule
  Diclofenac Potassium Tablets
  Tiapride Hydrochloride...
  Netilmicin Sulfate injection
  Ganciclovir injection

Jiangsu Lianshui Pharmaceutical Co., Ltd. was founded in 1958. It is a modern and high-tech private pharmaceutical enterprise engaged in the R&D, production and sales of drugs.

At present, there are 350 employees in the company. The company has various formulations such as small-volume injection, tablet, hard capsule, granule, has 103 medicine approval numbers, 54 of which are for small-volume injection and 49 for oral solid preparation.

The output and sales volume of small-volume injection occupy leading place in China. Levofloxacin lactate injection, dextromethorphan hydrobromide injection, lomefloxacin hydrochloride injection, itopride hydrochloride capsules have been successively rated as high-tech product of Science Technology Department of Jiangsu Province. Our products are sold well in China as well as in Southeast Asia, Africa, America, and other countries and regions.

According to enterprise development program and GMP requirement, the company purchased land covering 320mu in Lianshui Economic and Technological Development Zone of Jiangsu province for establishing Jiangsu Lianshui Pharmaceutical Science and Technology Industrial Park. The first-stage project occupies an area of 123mu, with the building area of 37,230 sq. m. The company has established small-volume injection manufacturing center, oral solid preparation manufacturing center, quality testing center, animal test center, power center, storage center with investment of 250 million Yuan RMB. Our oral solid preparation and small-volume injection has passed GMP certification edition 2010.

The company insists on the operation policy of "brand management, differentiated competition, cost leadership, win by quality". There are 80 national health insurance drugs, 44 national essential drugs, and 4 exclusive drugs. Based on the most advanced production equipment and reliable sterile production technology, the company is capable of producing 3.6 billion small-volume injections each year, and 5 billion tablets (granules, bags) of solid preparations. The annual sales revenue is 500 million Yuan RMB, and profit and tax are more than 100 million Yuan RMB.

The company is observing contracting and valuing credit enterprise of China, national high-tech enterprise, product quality trustworthy enterprise of China, anti-flu drug engineering and technological research center of Jiangsu province, and civilized unit of Jiangsu Province. Our products are evaluated as top-ten new products in China, high-quality and famous-brand products of China, high-quality well-known products of China, famous-brand products of Jiangsu, and famous trademark of Jiangsu.

The company strives to establish the largest small-volume injection manufacturer in China, and to develop into a internationalizing enterprise.

Home | About | Product | New Product | Feedback | Quality | Order | Sales network | Call of bide | HR | Contact | Chinese
Copyright(C)2008,Jiangsu Lianshui Pharmaceutical Co., Ltd. All Rights Reserved. Supported by  ChinaPharmNet Toocle
3d开奖分布图 河南福彩快三一定牛 黑龙江p62最新开奖 今天福建快3走势图 三分彩免费计划 湖北体彩11选5奖金表 炒股头像图片 河南福彩快3遗漏号码 福建体彩31选7彩经网 内蒙古快三结果 香港马会开奖结果直播